Capital markets·October 16, 2026 at 10:26 AM EDT·1 source
Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase
KMB -1.9%KVUE
KMB · last 30 trading days+10.8% since the news
News
What happened
- Kimberly-Clark is holding investor calls ahead of a possible bond sale.
- The financing would come as the closing of its pending acquisition of Kenvue nears.
Why it matters
The potential bond sale is relevant to debt-capital-markets and credit professionals because it may finance or support Kimberly-Clark’s pending acquisition.
What to watch. The possible bond sale and the closing of Kimberly-Clark’s pending acquisition of Kenvue.
Deal terms
acquisition
Kimberly-Clark Corp. → Kenvue Inc.
Value
—
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 13Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
- EarlierOct 14Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation (Rashi Shrivastava/Forbes)
- EarlierOct 15Kimberly Clark Corp.: Results of operations
- EarlierOct 15Kimberly-Clark Forecasts Quarterly Sales Decline Following Social-Media Firestorm in China
- First reported by BloombergOct 16Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase
Who is involved
acquiringKimberly-Clark Readies Bond Sale Ahead of Tylenol Maker PurchaseKenvue Inc.KVUE · targetKimberly-Clark Corp.KMB · buyer
CompanyThe deal
Sources (1)
Related
- Oct 19 · Kimberly-Clark Offers Bonds to Help Fund Tylenol Maker Takeover
- Oct 16 · Kimberly-Clark is having its best week in four years. Here's what is propelling shares higher
- Oct 15 · Kimberly-Clark Forecasts Quarterly Sales Decline Following Social-Media Firestorm in China
- Oct 15 · Kimberly Clark Corp.: Results of operations
- Oct 14 · Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation (Rashi Shrivastava/Forbes)
- Oct 13 · Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.